参考文献

1.吴恩惠，刘玉清，贺能树．介入性治疗学．北京：人民卫生出版社，1994.

2.祁吉，杨仁杰．医学影像学辞典．北京：北京科学技术出版社，1999.

3.郭启勇．介入放射学．北京：人民卫生出版社，2000.

4.李麟荪，贺能树，邹英华．介入放射学——基础与方法．北京：人民卫生出版社，2005.

5.李文华，杨仁杰．食管影像学．北京：人民卫生出版社，2003.

6.凌锋．介入神经放射学．北京：人民卫生出版社，1991.

7.余建明，曾军．血管路径图技术在DSA检查中的价值．实用放射学杂志，1994，10：555-556.

8.曲桂莲，张翼，郭建军，等．步进DSA技术在下肢动脉造影中的应用．医学影像学杂志，2001，11：135-136.

9.张晓龙，凌锋．三维数字减影血管造影在介入神经放射学中的价值．国外医学：脑血管疾病分册，2001，9：99-101.

10.张雪哲，熊琳，王武，等．CT导引下经皮细针穿刺活检的经验．中华放射学杂志，1998，3：136-139.

11.张雪哲，卢延，曾右鲁，等．CT导引下肾囊肿穿刺硬化剂治疗．中华放射学杂志，1989，6：337-339.

12.罗时石，王泽港，胡建伟，等．磁共振介入技术与原则．医学影像学杂志，2003，13：936-946.

13.李康安，赵斌，李成利，等．光学引导系统下低场开放式磁共振活检技术的临床应用．医学影像学杂志，2003，13：273-275.

14.李晓群，唐玉德，肖学红，等．MRI导引下经皮穿刺活检术的临床应用．影像诊断与介入放射学，2002，11：166-167.

15.董宝玮．临床介入性超声学．北京：中国科学技术出版社，1990：11-14.

16.郭启勇，等．介入放射学．北京：人民卫生出版社，2000：17-25.

17.凌锋，等．介入神经放射学在新世纪中的发展空间．介入放射学，2000，9：129-130.

18.王建华，王小林，等．腹部介入放射学．上海：上海医科大学出版社，1998：11-17.

19.吴恩惠，等．经肾肝排泄的水溶性碘造影剂．国外医学：临床放射学分册，1982，3：3-5.

20.陈星荣，等．造影剂及其副反应研究的进展．国外医学：临床放射学分册，1987，5：5-7.

21.冯晓源．Ultravist和泛影葡胺用于CT增强扫描不良反应的前瞻性随机单盲对比研究．中华放射学杂志，1993，27：96-98.

22.靳大川．胆石直接溶解剂的研究进展．临床荟萃，1995，10：246.

23.张志坚，李兆申，许国铭，等．内镜下逆行胆囊插管及直接溶石疗法．国外医学：内科分册，1993，20：150.

24.汪钟，郑植荃，等．现代血栓病学．北京：北京医科大学中国协和医科大学联合出版社，1997：523-532.

25.朱慧，刘伟，史蔚，等．重组人尿激酶原的体外变复性研究．生物工程学报，2000，16：150-154.

26.赵春梅，张洪涛，胡美浩．组织型纤溶酶原激活剂A链与尿激酶原B链嵌合分子的构建与表达．中国生物化学与分子生物学报，1999，15：528-531.

27.袁洪卫，林汉，朱锡霞，等．抗纤维蛋白-抗尿激酶双特异性单克隆抗体的体内外溶栓效果的研究．中国医学科学院院报，1998，20：357-360.

28.许国铭，李兆申．上消化道内镜学．上海：上海科学技术出版社，2003：23-138；513-530；556-563；571-638.

29.陈敏章，消化内镜的发展//李益农，陆星华．消化内镜学．北京：北京科学技术出版社，1995：3-6.

30.黄留业，宋波，刘运祥．双气囊电子内镜对小肠疾病的诊断价值．中华消化内镜杂志，2006，23：53-55.

31.李延斌，母树清，逄天秋．消化系统内镜的最新进展与应用．中国综合临床，2002，18：962-963.

32.祁吉，杨仁杰．当代放射学辞典．北京：人民卫生出版社，2011.

33.Guglielmi G，Vinuela F，Duckwiler G，et al. Endovascular treatment of posterior circulation aneurysms by electrothrombosis using electrically detachable coils. J Neurosurg，1992，77：515-524.

34.Gailloud P，Oishi S，Murphy K，et al. Three-dimensional fusion digital subtraction angiography：new reconstruction algorithm for simultaneous three-dimensional rendering of osseous and vascular information obtained during rotational angiography.AJNR Am J Neuroradiol，2005，26：908-911.

35.Touloupidis S，Rombis V，Vougiouklis N，et al. Digital subtraction angiography assisted ultrasound puncture in a pelvic kidney. Int Urol Nephrol，2003，35：467-470.

36.Leiner T，Kessels AG，Schurink GW，et al. Comparison of contrast-enhanced magnetic resonance angiography and digital subtraction angiography in patients with chronic critical ischemia and tissue loss. Invest Radiol，2004，39：435-444.

37.Hidajat N，Griesshaber V，Hildebrandt B，et al. Repetitive transarterial chemoembolization（rTACE）of hepatocellular carcinoma：comparisons between an arterial port system and conventional angiographic technique. Eur J Radiol，2004，51：6-11.

38.Vignali C，Lonzi S，Bargellini I，et al. Vascular injuries after percutaneous renal procedures：treatment by transcatheter embolization. Eur Radiol，2004，14：723-729.

39.Andrews RT，Binkert CA，et al. Digital subtraction fuoroscopy to enhance visualization during uterine fbroid embolization.Cardiovasc Intervent Radiol，2003，26：296-297.

40.Iwai R，Tsumura K，Kuwayama N，et al. Three-dimensional DSA imaging and 3-dimensional measurement of cross section for internal carotid artery stenosis. No To Shinkei，2003，55：661-667.

41.Caridi JG，Hawkins IF Jr，Klioze SD，et al. Carbon dioxide digital subtraction angiography：the practical approach. Tech Vasc Interv Radiol，2001，4：57-65.

42.Anxionnat R，Bracard S，Ducrocq X，et al. Intracranial aneurysms：clinical value of 3D digital subtraction angiography in the therapeutic decision and endovascular treatment. Radiology，2001，218：799-808.

43.Wiesent K，Barth K，Navab N，et al. Enhanced 3-D-reconstruction algorithm for C-arm systems suitable for interventional procedures. IEEE Trans Med Imaging，2000，19：391-403.

44.Talukdar AS，Wilson DL，et al. Modeling and optimization of rotational C-arm stereoscopic X-ray angiography. IEEE Trans Med Imaging，1999，18：604-616.

45.Picard L，Maurincomme E，Soderman M，et al. X-ray angiography in stereotactic conditions：techniques and interest for interventional neuroradiology. Stereotact Funct Neurosurg，1997，68：117-120.

46.Gazelle CS，Hagga JR，et al. Guided percutaneous biopsy of intraabdominal lesions. MR，1989，153：929-935.

47.Smith EH. Complications of percutaneous abdominal fne-needle biopsy. Radiology，1991，178：253-258.

48.Kuehne T，Weiss S，Brinkert F，et al. Catheter visualization with resonant markers at MR imaging-guided deployment of endovascular stents in swine. Radiology，2004，233：774-780.

49.Zangos S，Eichler K，Engelmann K，et al. MR-guided transgluteal biopsies with an open low-feld system in patients with clinically suspected prostate cancer：technique and preliminary results. Eur Radiol，2005，15：174-182.

50.Hinks RS，Bronskill MJ，Kucharczyk W，et al. MR systems for image-guided therapy. J Magn Reson Imaging，1998，8：19-25.

51.Barentsz JO. MR intervention in the pelvis：an overview and frst experiences in MR-guided biopsy in nodal metastases in urinary bladder cancer. Abdom Imaging，1997，22：524-530.

52.Paetzel C，Zorger N，Bachthaler M，et al. Feasibility of MR-guided angioplasty of femoral artery stenosis using real-time imaging and intraarterial contrast-enhanced MR angiography. Rofo，2004，176：1232-1236.

53.Fischer U，Vosshenrich R，Doler W，et al. MR imaging-guided breast intervention：experience with two systems. Radiology，1995，195：533-538.

54.Bock M，Volz S，Zuhlsdorff S，et al. MR-guided intravascular procedures：real-time parameter control and automated slice positioning with active tracking coils. J Magn Reson. Imaging，2004，19：580-589.

55.Kuehne T，Saeed M，Higgins CB，et al. Endovascular stents in pulmonary valve and artery in swine：feasibility study of MR imaging-guided deployment and post-interventional assessment. Radiology，2003，226：475-481.

56.Vogl TJ，Balzer JO，Mack MG，et al. Hybrid MR interventional imaging system：combined MR and angiography suites with single interactive table. Feasibility study in vascular liver tumor procedures. Eur Radiol，2002，12：1394-1400.

57.Viehweg P，Heinig A，Amaya B，et al. MR-guided interventional breast procedures considering vacuum biopsy in particular.Eur J Radiol，2002，42：32-39.

58.Kuhl CK，Morakkabati N，Leutner CC，et al. MR imaging-guided large-core（14-gauge）needle biopsy of small lesions visible at breast MR imaging alone. Radiology，2001，220：31-39.

59.Tacke J，Speetzen R，Adam G，et al. Experimental MR imaging-guided interstitial cryotherapy of the brain. AJNR Am J Neuroradiol，2001，22：431-440.

60.Wacker FK，Faiss S，Reither K，et al. MR imaging-guided biliary drainage in an open low-field system：first clinical experiences. Rofo，2000，172：744-747.

61.Yuichi M，Fernando V，Satoshi T，et al. Matrix：new bio-absorbable polymeric coils for treatment of intracranial aneurysms.International Congress Series，2002，1247：119-126.

62.Mottu F，Rufenacht DA，Laurent A，et al. Iodine-containing cellulose mixed esters as radiopaque polymers for direct embolization of cerebral aneurysms and arteriovenous malformations. Biomaterials，2002，23：121-131.

63.Femando C，Glenn M，et al. Management of Residual Stones. Urol Clin of N Amer，2000，27：347-354.

64.Domia E，Donia G，Malagola G，et al. Experience with instrumental chemolysis for urolithiasis. J Urol，2003，170：1105-1110.

65.Hoesl CE，Altwein JE，et al. The probiotic approach an alternative treatment option in urology. Eur Urol，2005，47：288-296.

66.Manabu S，Nobuyoshi N，et al. Molecular，sequencing and expressing of cDNA encoding serine protease with fbrinolytic activity from earthworm. Biosci Biotedmol Biochean，2001，65：1575-1580.

67.Macdonald S，Edwards RD，Moss JG. Patient tolerance of cervical esophageal metallic stents. J Vasc Interv Radiol，2000，11：891-898.

68.Shim CS，Jung IS，Bhandari S，et al. Management of malignant strictures of the cervical esophagus with a newly-designed self-expanding metal stent. Endoscopy，2004，36：554-557.

69.Kozarek RA，Raltz S，Brugge WR，et al. Prospective multicenter trial of esophageal Z-stent placement for malignant dysphagia and tracheoesophageal fstula. Gastrointest Endosc，1996，44：562-567.

70.Shim CS，Cho YD，Moon JH，et al. Fixation of a modifed covered esophageal stent：its clinical usefulness for preventing stent migration. Endoscopy，2001，33：843-848.

71.Verschuur EM，Homs MY，Steyerberg EW，et al. A new esophageal stent design（Niti-S stent）for the prevention of migration：a prospective study in 42 patients. Gastrointest Endosc，2006，63：134-140.

72.Dua KS，Kozarek R，Kim J，et al. Self-expanding metal esophageal stent with anti-refux mechanism. Gastrointest Endosc，2001，53：603-613.

73.Homs MY，Wahab PJ，Kuipers EJ，et al. Esophageal stents with antirefux valve for tumors of the distal esophagus and gastric cardia：a randomized trial. Gastrointest Endosc，2004，60：695-702.

74.Shim CS，Jung IS，Cheon YK，et al. Management of malignant stricture of the esophagogastric junction with a newly designed self-expanding metal stent with an antirefux mechanism. Endoscopy，2005，37：335-339.

75.Parkin DM，Bray F，Ferlay J，et al. Global cancer statistics，2002.CA Cancer J Clin，2005，55：74-108.

76.Llovet JM，Burroughs A，Bruix J. Hepatocellular carcinoma. Lancet，2003，362：1907-1917.

77.Bismuth H，Majno PE. Hepatobiliary surgery. J Hepatol，2000，32 Suppl 1：208-224.

78.Vassiliou I，Arkadopoulos N，Theodosopoulos T，et al. Surgical approaches of resectable synchronous colorectal liver metastases：timing considerations. World J Gastroenterol，2007，13：1431-1434.

79.Cammà C，Schepis F，Orlando A，et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma：metaanalysis of randomized controlled trials. Radiology，2002，224：47-54.

80.Llovet JM，Real MI，Montaña X，et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma：a randomised controlled trial. Lancet，2002，359：1734-1739.

81.Jelic S，Sotiropoulos GC. Hepatocellular carcinoma：ESMO Clinical Practice Guidelines for diagnosis，treatment and followup. Ann Oncol，2010，21 Suppl 5：v59-v64.

82.Wu CC，Ho YZ，Ho WL，et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma：a reappraisal. Br J Surg，1995，82：122-126.

83.Majno PE，Adam R，Bismuth H，et al. Infuence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg，1997，226：688-701；discussion 701-703.

84.Suzuki Y，Fujimoto Y，Hosoki Y，et al. Clinical utility of sequential imaging of hepatocellular carcinoma by contrast-enhanced power Doppler ultrasonography. Eur J Radiol，2003，48：214-219.

85.Tajima T，Honda H，Taguchi K，et al. Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules：CT angiography and pathologic correlation. AJR Am J Roentgenol，2002，178：885-897.

86.Brown DB，Pilgram TK，Darcy MD，et al. Hepatic arterial chemoembolization for hepatocellular carcinoma：comparison of survival rates with different embolic agents. J Vasc Interv Radiol，2005，16：1661-1666.

87.Bruix J，Sala M，Llovet JM. Chemoembolization for hepatocellular carcinoma. Gastroenterology，2004，127：S179-S188.

88.Duxbury MS，Garden OJ. Giant haemangioma of the liver：observation or resection? Dig Surg，2010，27：7-11.

89.Mehrabi A，Kashfi A，Fonouni H，et al. Primary malignant hepatic epithelioid hemangioendothelioma：a comprehensive review of the literature with emphasis on the surgical therapy. Cancer，2006，107：2108-2121.

90.Fan J，Wu ZQ，Tang ZY，et al. Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein. World J Gastroenterol，2001，7：28-32.

91.Lin MT，Kuo PH. Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma.JRSM Short Rep，2010，1：6.

92.Geschwind JF，Kaushik S，Ramsey DE，et al. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol，2002，13：1163-1166.

93.Khan W，Sullivan KL，McCann JW，et al. Moxifoxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions：a pilot study. AJR Am J Roentgenol，2011，197：W343-W345.

94.Kubota K，Hisa N，Nishikawa T，et al. Evaluation of hepatocellular carcinoma after treatment with transcatheter arterial chemoembolization：comparison of Lipiodol-CT，power Doppler sonography，and dynamic MRI. Abdom Imaging，2001，26：184-190.

95.Llovet JM，Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma：Chemoembolization improves survival. Hepatology，2003，37：429-442.

96.Lo CM，Ngan H，Tso WK，et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology，2002，35：1164-1171.

97.Zhong JH，Li LQ. Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma：A meta-analysis. Hepatol Res，2010，40：943-953.

98.Vogl TJ，Naguib NN，Nour-Eldin NE，et al. Review on transarterial chemoembolization in hepatocellular carcinoma：palliative，combined，neoadjuvant，bridging，and symptomatic indications. Eur J Radiol，2009，72：505-516.

99.Chua TC，Liauw W，Saxena A，et al. Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma. Liver Int，2010，30：166-174.

100.Bouchard-Fortier A，Lapointe R，Perreault P，et al. Transcatheter arterial chemoembolization of hepatocellular carcinoma as a bridge to liver transplantation：a retrospective study. Int J Hepatol，2011，2011：974514.

101.Lesurtel M，Müllhaupt B，Pestalozzi BC，et al. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma：an evidence-based analysis. Am J Transplant，2006，6：2644-2650.

102.Zhu AX，Abou-Alfa GK. Expanding the treatment options for hepatocellular carcinoma：combining transarterial chemoembolization with radiofrequency ablation. JAMA，2008，299：1716-1718.

103.Wang N，Guan Q，Wang K，et al. TACE combined with PEI versus TACE alone in the treatment of HCC：a meta-analysis.Med Oncol，2011，28：1038-1043.

104.Cabibbo G，Latteri F，Antonucci M，et al. Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Clin Pract Gastroenterol Hepatol，2009，6：159-169.

105.Lee E，Leon Pachter H，Sarpel U. Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors. Int J Hepatol，2012，2012：471203.

106.Mavligit GM，Zukwiski AA，Ellis LM，et al. Gastrointestinal leiomyosarcoma metastatic to the liver. Durable tumor regression by hepatic chemoembolization infusion with cisplatin and vinblastine. Cancer，1995，75：2083-2088.

107.Takayasu K，Arii S，Ikai I，et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology，2006，131：461-469.

108.Sueyoshi E，Hayashida T，Sakamoto I，et al. Vascular complications of hepatic artery after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma. AJR Am J Roentgenol，2010，195：245-251.

109.Llovet JM，Ricci S，Mazzaferro V，et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med，2008，359：378-390.

110.Sansonno D，Lauletta G，Russi S，et al. Transarterial chemoembolization plus sorafenib：a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma：a randomized clinical trial. Oncologist，2012，17：359-366.

111.Raoul JL，Sangro B，Forner A，et al. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma：available evidence and expert opinion on the use of transarterial chemoembolization. Cancer Treat Rev，2011，37：212-220.

112.Wong KM，Tan BS，Taneja M，et al. Cone beam computed tomography for vascular interventional radiology procedures：early experience. Ann Acad Med Singapore，2011，40（7）：308-314.

113.Miyayama S，Yamashiro M，Hattori Y，et al. Efficacy of cone-beam computed tomography during transcatheter arterial chemoembolization for hepatocellular carcinoma. Jpn J Radiol，2011，29（6）：371-377.

114.Meyer BC，Witschel M，Frericks BB，et al. The value of combined soft-tissue and vessel visualisation before transarterial chemoembolization of the liver using C-arm computed tomography. Eur Radiol，2009，19（9）：2302-2309.

115.Froelich JJ，Wagner HJ，Ishaque N，et al. Comparison of C-arm CT fluoroscopy and conventional fluoroscopy for percutaneous biliary drainage procedures. J Vasc Interv Radiol，2000，11（4）：477-482.

116.Fischbach F，Thormann M，Seidensticker M，et al. Assessment of fast dynamic imaging and the use of Gd-EOB-DTPA for MR-guided liver interventions. J Magn Reson Imaging，2011，34（4）：874-879.

117.Morita Y，Ito N，Hikida H，et al. Non-invasive magnetic resonance imaging-guided focused ultrasound treatment for uterine fbroids - early experience. Eur J Obstet Gynecol Reprod Biol，2008，139（2）：199-203.

118.吴恩惠等．介入性放射学．北京：人民卫生出版社，1989：2-17.

119.Yuichi M，Fernando V，Satoshi T. Matrix：new bio-absorbable polymeric coils for treatment of intracranial aneurysms.International Congress Series，2002，1247：119-126.

120.Doppman JL，Girton M，Kahn ER. Proximal versus peripheral hepatic artery embolization：experimental study in monkeys.Radiology，1978，128：577.

121.郭新英，张一平，孔芙蓉，等．介入诊疗与护理．郑州：河南科学技术出版社，2000：58-70.

122.Mitchell E，Tublin，Franklin N，et al. Effect of injection rate of contrast medium on pancreatic and hepatic spiral CT.Radiology，1999，210：97-101.

123.Ellis JH，Cohan RH，Sonnad SS，et al. Selected use of radiologic low-osmolality contrast media in the 1990’s. Radiology，1996，200：297-311.

124.Katayama H，Yamaguchi K，Kozuka T，et al. Adverse reactions to ionic and nonionic contrast media：a report from the Japanese Committee on the Safety of Contrast Media. Radiology，1990，175：621-628.

125.Hellstern A，Leuschner M，Frenk H，et al. Gallstone dissolution with MTBE：how to avoid complications. Gut，1990，31：922-925.

126.Kapoor BS，Agarwal AK，Khanna NN，et al. Prediction of gallstone composition by ultrasound：implication for non-surgical therapy. Br J Radiol，1995，68：459-462.

127.王洪武，金发光，柯明耀．支气管介入治疗．北京：人民卫生出版社，2012：17-41.

128.金发光，钱桂生，傅恩清，等．支气管镜在诊疗过程中发生的严重并发症及防治方法探讨．中国急救医学，2005，25（5）：315-317.

129.王洪武，张楠，李冬妹，等．与气管镜介入治疗有关的大出血的应急处理．中华临床医师杂志（电子版），2012，6（5）：199-200.